Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

01-09-2020

Market access for immune-oncology products in the EU

In this article, published in Volume 22 September 2020 of Pharmafocus, Claes Buxfeldt discusses key considerations in early development to succeed with market access for immune-oncology products in the EU.
19-06-2019

Importance of Excellence in Scientific and regulatory Communication

In this white paper, Lisa Peluso discusses how excellent communications are the backbone of streamlined, efficient programs achieving approval and market access.
06-05-2019

4 ways that HTA will change under the new European regulation

In this white paper NDA's CEO, Johan Strömquist, discusses four ways that Health Technology Assessments will change under the new proposed European Regulation.
23-04-2018

The rationales and results of engaging early with regulators and HTA bodies.

Learn about the rationales and results of engaging early with regulators and HTA bodies.
13-06-2017

Partnership with Payers: Communicating and Negotiating with Impact

In this white paper you will learn about why excellence in communications is critical when it's time to defend the value and negotiate pricing. Prepare to win.
03-05-2017

Maximising value in early development

In this white paper you will learn how to maximise the value of your product by having an early development strategy